AlphaStar Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.28M Sell
23,042
-1,412
-6% -$262K 0.3% 61
2025
Q1
$5.12M Sell
24,454
-8,579
-26% -$1.8M 0.52% 32
2024
Q4
$5.87M Buy
33,033
+3,607
+12% +$641K 0.61% 25
2024
Q3
$5.81M Buy
29,426
+1,849
+7% +$365K 0.46% 34
2024
Q2
$4.73M Buy
27,577
+1,242
+5% +$213K 0.44% 31
2024
Q1
$4.8M Buy
26,335
+2,339
+10% +$426K 0.49% 30
2023
Q4
$3.72M Buy
23,996
+581
+2% +$90K 0.34% 41
2023
Q3
$3.49M Sell
23,415
-483
-2% -$72K 0.44% 29
2023
Q2
$3.22M Buy
23,898
+73
+0.3% +$9.84K 0.36% 37
2023
Q1
$3.8M Sell
23,825
-7,894
-25% -$1.26M 0.32% 47
2022
Q4
$5.13M Buy
31,719
+8,224
+35% +$1.33M 0.53% 37
2022
Q3
$3.15M Buy
23,495
+1,226
+6% +$165K 0.34% 52
2022
Q2
$3.41M Buy
22,269
+1,415
+7% +$217K 0.32% 57
2022
Q1
$3.38M Buy
20,854
+619
+3% +$100K 0.27% 69
2021
Q4
$2.75M Sell
20,235
-4,106
-17% -$558K 0.22% 95
2021
Q3
$2.64M Buy
24,341
+9,783
+67% +$1.06M 0.18% 102
2021
Q2
$1.64M Buy
14,558
+1,532
+12% +$173K 0.21% 92
2021
Q1
$1.41M Sell
13,026
-82
-0.6% -$8.88K 0.22% 85
2020
Q4
$1.47M Buy
13,108
+5,422
+71% +$606K 0.25% 80
2020
Q3
$657K Buy
7,686
+2,416
+46% +$207K 0.13% 106
2020
Q2
$530K Buy
5,270
+536
+11% +$53.9K 0.11% 109
2020
Q1
$380K Sell
4,734
-25
-0.5% -$2.01K 0.09% 129
2019
Q4
$421K Buy
4,759
+513
+12% +$45.4K 0.09% 140
2019
Q3
$322K Sell
4,246
-306
-7% -$23.2K 0.08% 156
2019
Q2
$331K Sell
4,552
-93
-2% -$6.76K 0.08% 160
2019
Q1
$374K Buy
4,645
+207
+5% +$16.7K 0.1% 140
2018
Q4
$409K Sell
4,438
-25
-0.6% -$2.3K 0.13% 125
2018
Q3
$422K Sell
4,463
-193
-4% -$18.2K 0.12% 142
2018
Q2
$431K Sell
4,656
-456
-9% -$42.2K 0.14% 142
2018
Q1
$484K Buy
5,112
+261
+5% +$24.7K 0.18% 103
2017
Q4
$469K Buy
+4,851
New +$469K 0.12% 107